Back to competency map

Clinical competency

Understand psilocybin-assisted therapy as a rapid-acting intervention for depression

Facilitators require knowledge of the therapeutic context, including that psilocybin is being investigated as a rapid-acting treatment for major depressive disorder. This includes understanding the expected timeframe of symptom assessment and response.

Primary clinical guidelineModern clinical

Looking for something specific? Ask Blossom

Guidelines

1

Courses

0

Providers

0

Protocols

1

Classification

Care stages

Protocol families

Source quality

Protocol paper

Linked sources

The guidelines, courses, and providers that evidence this competency. Full lists are a Blossom Pro feature.

Linked guidelines (1)

  • Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial

    PsilocybinEvidence score: 90

Unlock every linked source

See all linked guidelines, courses, and providers behind this competency, plus the full competency graph.

Understand psilocybin-assisted therapy as a rapid-acting intervention for depression - Clinical Competency | Blossom